HCPLive Podcasts

Surveying the Dermatological Treatment Landscape 31.01.2021 25:13 ↓

In this Derm Discussions, Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious. 

Cardiovascular Guidelines in Diabetics with Dr. George Bakris 25.01.2021 34:50 ↓

The University of Chicago hypertension expert discusses new ADA recommendations for cardiovascular risk management.

New and Emerging Therapies for the Management of Itch 21.12.2020 30:20 ↓

In this Derm Discussions, Peter Lio, MD, discusses the difficulties treating itch as well as alternative—and perhaps surprising—therapeutic options.

Elliott Vichinsky, MD: Voxelotor and New HOPE Data 08.12.2020 24:57 ↓

The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.

Edmund Tsui, MD: A Discussion on AAO 2020 Virtual 13.11.2020 13:01 ↓

Edmund Tsui, MD, talks the new AAO virtual format as well as presentations that have particularly caught his attention.

Unlocking the Pediatric Dermatology Toolbox 10.11.2020 40:29 ↓

In this Derm Discussions, Lisa Swanson, MD, and Brad Glick, DO, FAAD, discuss a wide range of dermatological conditions faced by pediatric patients—from acne to atopic dermatitis, and everything in between.

What's New in Skin of Color? 22.10.2020 20:00 ↓

In this Derm Discussions, Seemal Desai, MD, joins Brad Glick, DO, for an update on dermatologic burdens in people of color.

Man Fung Yuen, MD, PhD: The Future of Hepatitis B Treatment 22.09.2020 24:06 ↓

Dr. Yuen discusses some new treatments in the pipeline and how personalized medicine could make an impact in HBV treatment. 

Alan Kaye, MD, PhD: Treating Pain Traditionally and with Alternate Therapies 22.09.2020 27:45 ↓

Alan Kaye, MD, PhD, joins DocTalk during Pain Awareness Month to discuss opioids, alternate pain therapies, and caring for patients with pain.

Theresa Cerulli, MD: ADHD Students Struggling During COVID-19 School Year 19.09.2020 22:04 ↓

Dr. Cerulli discusses some ways ADHD can manage an upheaval in routine during COVID-19.

Joshua Mali, MD: Hope for Patients with Wet AMD 18.09.2020 15:20 ↓

Dr. Mali talks about advancements in treatment and screening for Wet AMD.

Returning to Sports During COVID-19 14.08.2020 29:53 ↓

Dr. Louis Kovacs and Dr. Evan Lipson discuss the risk of playing youth, college, and professional sports during the ongoing pandemic.

George Everly, PhD: The Mental Health Burdens of COVID-19 05.08.2020 25:39 ↓

George Everly, PhD, discusses some of the pitfalls people face due to the ongoing pandemic. 

Mark Smith, MD, Phd: The Anxiousness of Coming Out of Quarantine 27.05.2020 22:26 ↓

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

Biologics for Inflammatory Care, COVID-19 Research 18.05.2020 25:20 ↓

Dr. Ian Pavord discusses new meta-analyses of dupilumab planned for ATS 2020.

COVID-19 Health Inequity 11.05.2020 23:41 ↓

Panagis Galiatsatos, MD, MHS, joins to discuss the underlying issues and potential solutions to COVID-19 patient disparities.

Daniel Kiernan, MD: Dexycu for Inflammation Post-Vitreoretinal Surgery 07.05.2020 5:55 ↓

Discussing a would-be ARVO 2020 presentation examining the use of anterior chamber intracameral dexamethasone drug-delivery suspen for postoperative inflammation in patients undergoing vitreoretinal surgery.

Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients 12.04.2020 17:27 ↓

Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.

Tezepelumab for Atopic Diseases 10.04.2020 15:26 ↓

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

Respiratory Health During COVID-19 06.04.2020 20:08 ↓

Al Rizzo, MD, CMO of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.

Dupilumab for Severe Pediatric Atopic Dermatitis 04.04.2020 13:49 ↓

Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.

Dr. Kaneko: PLO FLOW TAVR, July Effect, & Alternative Access TAVR 03.04.2020 12:32 ↓

Dr. Kaneko, a cardiac surgeon at Brigham and Women's Hospital, breaks down a trio of studies he was associated with from ACC.20, including a look into PLO FLOW TAVR, the July Effect, and alternative access TAVR.